LATEST ALERTS
Health and science
Researchers’ direst warnings on oral CBD should be taken with a lethal dose of salt
25th May 2023 - Blogs |
Researchers at the US Food and Drug Administration (FDA) recently published a review on the toxicity of orally-consumed CBD, largely echoing worries outlined in other safety reviews. So how worried should we be?
Podcast: Groundbreaking win for hemp in Poland’s high court
10th May 2023 - Podcasts |
Kombinat Konopny CEO and founder Maciej Kowalski talks to podcast host Oliver Prescott about the company’s win in Poland’s high court, subsequent changes in the industry and current cannabis food policy in Europe
The pay and the pain – study reveals little about the real value of medical cannabis
20th April 2023 - Blogs |
A new study of the relationship between opioids and cannabis via payments to doctors in US states offers little towards understanding the potential of cannabis as a substitute for opioids
Cannabis good, or cannabis bad? However you see it, we’ve got a stat for that
6th April 2023 - Blogs |
While statistics are vital to understanding our world, they are often misunderstood – and that can be important when it comes to forming opinions and laws on controversial issues such as cannabis
Yellow card offence – but comments are a long way from being a dismissal of CBD
22nd March 2023 - Blogs |
Comments by the chair of the UK Committee on Toxicity (COT) about reactions to CBD have stirred up a hornet’s nest – but the furore suggests a misunderstanding of what he actually said
Podcast: Fighting the Kanavape legal battle – what was it like and what challenges is the EU CBD industry still facing?
7th March 2023 - Podcasts |
Kanavape founder Sebastien Beguerie talks with CannIntelligence podcast host Tiziana Cauli about his judicial battle leading to a crucial European Court of Justice ruling which established CBD legal status across Europe
CBD brands apply for certification as Google lifts ads ban in some parts of US
10th February 2023 - News analysis |
Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US
US FDA issues guidance for development of cannabis-based medical drugs
27th January 2023 - News analysis |
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
Rules adopted for low-THC medical cannabis oil programme…
26th January 2023 - Alerts | Georgia US, North America, United States |
Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales
19th January 2023 - News analysis |
CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies
Much-needed research into SCRAs’ huge medical potential faces high barriers
12th January 2023 - Blogs |
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Pain, pot and placebos – flawed study fails to reveal their true relationship
22nd December 2022 - Blogs |
Despite what its authors claim, a new and widely reported study fails to establish that the analgesic properties of cannabis can be largely attributable to the placebo effect
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Cannabis and dopamine – potential good news for bipolar disorder sufferers
13th December 2022 - Blogs |
New research suggests that the effect of cannabis on dopamine may help to treat certain symptoms of bipolar disorder, with a reduced tendency to engage in risky behaviours and some improvement in cognitive ability
US medical cannabis and CBD research bill sent for presidential approval…
17th November 2022 - Alerts | North America, United States |
Mexico cannabis industry doubtful of recreational bill approval before 2024
7th November 2022 - News analysis |
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
New health committee chair served during legalisation of CBPMs…
3rd November 2022 - Alerts | Europe, United Kingdom |
UK standards authority challenges CBD product marketing disguised as content
28th October 2022 - News analysis |
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
UK scientist says medicinal cannabis research in the country lagging behind
21st October 2022 - News analysis |
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
Cannabis & Me – critics fear bias before major psychiatric study gets under way
20th October 2022 - News analysis |
A major new study into the impact of cannabis on the brain has attracted controversy and accusations of bias from within the industry before it even begins
Cannabis consumption up, cigarette smoking down in latest US Gallup poll
18th October 2022 - News analysis |
Smoking cigarettes is going out of fashion, but having smoked cannabis is becoming much more common in the US, according to recent research conducted by analytics and polling firm Gallup
Cannabis may help against opioids – but this latest study doesn’t tell us much
6th October 2022 - Blogs , News analysis |
Reducing opioid dependence is a primary goal of medical cannabis programmes, but there remains a need for rigorous science when making decisions about the interaction between cannabis and opioid use for pain
Breakthrough cannabis study finds CBD can reduce psychoactive effects of THC
5th October 2022 - News analysis |
A recent study has shown that CBD can reduce the psychoactive effects of THC – a discovery which could advance the clinical application of medical cannabis
With midterms coming, what has the Biden administration ever done for us?
15th September 2022 - News analysis |
As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform
How will open access to federally funded research affect US cannabis science?
14th September 2022 - Blogs |
The Biden Administration recently released a memorandum requiring research receiving federal funds to be made available to the public without charge. But what effect will this have on cannabis research?
A microdosing inhaler: just one of the many new innovations for psychedelics
26th August 2022 - News analysis |
A new conceptual inhaler designed around the idea of controlled microdosing could eventually lead to a product capable of administering precise amounts of active ingredients such as CBD, nicotine or even psychedelics
A breathalyser for cannabis impairment? The search to find a reliable test goes on
23rd August 2022 - News analysis |
US law enforcement is working alongside toxicologists and cannabis breathalyser developer Cannabix Technologies to test and compare various methods of detecting cannabis intoxication
Move towards granting new US research cannabis licence following slow start
22nd August 2022 - News analysis |
The US Drug Enforcement Administration (DEA) has issued a pre-solicitation notice to approved medical cannabis producers, the next step in securing new suppliers of cannabis for research purposes after a monopoly was ended
Could cannabis help improve outcomes for patients badly afflicted by Covid?
18th August 2022 - Blogs , News analysis |
A study published this month provides further evidence that cannabis could be helpful in treating severe late-stage Covid-19
Committee recommendations for CBD products published…
29th July 2022 - Alerts | Canada, North America |
No magic solution: EFSA ingestible CBD safety concerns won’t be resolved quickly
1st July 2022 - Blogs , News analysis |
It looks like there will be no easy or quick solutions to addressing the data gaps the European Food Safety Authority (EFSA) requires to reach a conclusion on the safety of CBD as an ingestible ingredient
Zurich seeks cannabis users for pilot project…
28th June 2022 - Alerts | Europe, Switzerland |
EU novel food applications: the science behind what EFSA says it wants to know
27th June 2022 - News analysis |
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point
Canada can teach Germany about pitfalls of legalising recreational cannabis
17th June 2022 - News analysis |
Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis
Lack of quality science on cannabis and pain leaves room for fake news and myth
16th June 2022 - Blogs , News analysis |
“It’s a myth that cannabis relieves pain,” declared the Daily Mail. But that is not what the study it was reporting said at all
How do you tell if a user is under the influence? It’s still a testing problem
14th June 2022 - News analysis |
While cannabis use is now legal in many US states, there is as yet no reliable test to determine whether, or how far, a user may be “under the influence”
Lausanne aims to become home to Switzerland’s second cannabis trial
8th June 2022 - News analysis |
Lausanne could become the second Swiss city after Basel to launch a recreational cannabis trial this year. But while Basel’s pilot will involve just 400 participants, Lausanne is aiming for triple that number
Australian companies looking to sell CBD treatments online with prescriptions
8th June 2022 - News analysis |
Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription goods
Off the hook – research reveals youth health benefits of legalising cannabis
31st May 2022 - Blogs , News analysis |
A six-year study of young adult behaviour reveals that when and where cannabis use is legalised, young people’s use of alcoho. and tobacco drops – and so does the use, and misuse, of pain-relieving prescription drugs
Mental health, addiction treatments with psychedelics: could the UK lead the way?
27th May 2022 - News analysis |
Strangely, Brexit and then the Covid-19 pandemic have combined to create ideal conditions for the UK to potentially become a leader in psychedelics research
Pennsylvania medical cannabis vape recall leaves patients stranded
13th May 2022 - News analysis |
A widespread recall of cannabis concentrates sold for vaping at medical cannabis dispensaries in the US state of Pennsylvania has left patients with more questions than answers about who to trust
Argentina approves law to establish legal framework for cannabis and hemp
13th May 2022 - News analysis |
Members of the Argentina Chamber of Deputies approved a law on 5th May that would establish a legal framework for the production, sale and export of medical cannabis as well as industrial hemp, a decision president Alberto Fernández says could generate 10,000 jobs in the South American country
